318 related articles for article (PubMed ID: 22474372)
1. Structures of KIX domain of CBP in complex with two FOXO3a transactivation domains reveal promiscuity and plasticity in coactivator recruitment.
Wang F; Marshall CB; Yamamoto K; Li GY; Gasmi-Seabrook GM; Okada H; Mak TW; Ikura M
Proc Natl Acad Sci U S A; 2012 Apr; 109(16):6078-83. PubMed ID: 22474372
[TBL] [Abstract][Full Text] [Related]
2. Synergistic interplay between promoter recognition and CBP/p300 coactivator recruitment by FOXO3a.
Wang F; Marshall CB; Li GY; Yamamoto K; Mak TW; Ikura M
ACS Chem Biol; 2009 Dec; 4(12):1017-27. PubMed ID: 19821614
[TBL] [Abstract][Full Text] [Related]
3. Mapping the interactions of the p53 transactivation domain with the KIX domain of CBP.
Lee CW; Arai M; Martinez-Yamout MA; Dyson HJ; Wright PE
Biochemistry; 2009 Mar; 48(10):2115-24. PubMed ID: 19220000
[TBL] [Abstract][Full Text] [Related]
4. Structural and mechanistic insights into the interaction of the circadian transcription factor BMAL1 with the KIX domain of the CREB-binding protein.
Garg A; Orru R; Ye W; Distler U; Chojnacki JE; Köhn M; Tenzer S; Sönnichsen C; Wolf E
J Biol Chem; 2019 Nov; 294(45):16604-16619. PubMed ID: 31515273
[TBL] [Abstract][Full Text] [Related]
5. Cooperativity in transcription factor binding to the coactivator CREB-binding protein (CBP). The mixed lineage leukemia protein (MLL) activation domain binds to an allosteric site on the KIX domain.
Goto NK; Zor T; Martinez-Yamout M; Dyson HJ; Wright PE
J Biol Chem; 2002 Nov; 277(45):43168-74. PubMed ID: 12205094
[TBL] [Abstract][Full Text] [Related]
6. HTLV-1 HBZ protein deregulates interactions between cellular factors and the KIX domain of p300/CBP.
Cook PR; Polakowski N; Lemasson I
J Mol Biol; 2011 Jun; 409(3):384-98. PubMed ID: 21497608
[TBL] [Abstract][Full Text] [Related]
7. Molecular characterization of HTLV-1 Tax interaction with the KIX domain of CBP/p300.
Ramírez JA; Nyborg JK
J Mol Biol; 2007 Sep; 372(4):958-969. PubMed ID: 17707401
[TBL] [Abstract][Full Text] [Related]
8. Structural basis for cooperative transcription factor binding to the CBP coactivator.
De Guzman RN; Goto NK; Dyson HJ; Wright PE
J Mol Biol; 2006 Feb; 355(5):1005-13. PubMed ID: 16253272
[TBL] [Abstract][Full Text] [Related]
9. A Dual-Site Inhibitor of CBP/p300 KIX is a Selective and Effective Modulator of Myb.
Joy ST; Henley MJ; De Salle SN; Beyersdorf MS; Vock IW; Huldin AJL; Mapp AK
J Am Chem Soc; 2021 Sep; 143(37):15056-15062. PubMed ID: 34491719
[TBL] [Abstract][Full Text] [Related]
10. Mutations in multiple domains of c-Myb disrupt interaction with CBP/p300 and abrogate myeloid transforming ability.
Pattabiraman DR; Sun J; Dowhan DH; Ishii S; Gonda TJ
Mol Cancer Res; 2009 Sep; 7(9):1477-86. PubMed ID: 19737967
[TBL] [Abstract][Full Text] [Related]
11. Conformational control of the binding of the transactivation domain of the MLL protein and c-Myb to the KIX domain of CREB.
Korkmaz EN; Nussinov R; Haliloğlu T
PLoS Comput Biol; 2012; 8(3):e1002420. PubMed ID: 22438798
[TBL] [Abstract][Full Text] [Related]
12. MLL-AFX requires the transcriptional effector domains of AFX to transform myeloid progenitors and transdominantly interfere with forkhead protein function.
So CW; Cleary ML
Mol Cell Biol; 2002 Sep; 22(18):6542-52. PubMed ID: 12192052
[TBL] [Abstract][Full Text] [Related]
13. Leu628 of the KIX domain of CBP is a key residue for the interaction with the MLL transactivation domain.
Arai M; Dyson HJ; Wright PE
FEBS Lett; 2010 Nov; 584(22):4500-4. PubMed ID: 20969867
[TBL] [Abstract][Full Text] [Related]
14. Biochemical and structural characterization of an intramolecular interaction in FOXO3a and its binding with p53.
Wang F; Marshall CB; Yamamoto K; Li GY; Plevin MJ; You H; Mak TW; Ikura M
J Mol Biol; 2008 Dec; 384(3):590-603. PubMed ID: 18824006
[TBL] [Abstract][Full Text] [Related]
15. Structural insights into TAZ2 domain-mediated CBP/p300 recruitment by transactivation domain 1 of the lymphopoietic transcription factor E2A.
Lochhead MR; Brown AD; Kirlin AC; Chitayat S; Munro K; Findlay JE; Baillie GS; LeBrun DP; Langelaan DN; Smith SP
J Biol Chem; 2020 Mar; 295(13):4303-4315. PubMed ID: 32098872
[TBL] [Abstract][Full Text] [Related]
16. Molecular Basis for the Mechanism of Constitutive CBP/p300 Coactivator Recruitment by CRTC1-MAML2 and Its Implications in cAMP Signaling.
Clark MD; Kumar GS; Marcum R; Luo Q; Zhang Y; Radhakrishnan I
Biochemistry; 2015 Sep; 54(35):5439-46. PubMed ID: 26274502
[TBL] [Abstract][Full Text] [Related]
17. Cooperative regulation of p53 by modulation of ternary complex formation with CBP/p300 and HDM2.
Ferreon JC; Lee CW; Arai M; Martinez-Yamout MA; Dyson HJ; Wright PE
Proc Natl Acad Sci U S A; 2009 Apr; 106(16):6591-6. PubMed ID: 19357310
[TBL] [Abstract][Full Text] [Related]
18. Genetic interaction between mutations in c-Myb and the KIX domains of CBP and p300 affects multiple blood cell lineages and influences both gene activation and repression.
Kasper LH; Fukuyama T; Lerach S; Chang Y; Xu W; Wu S; Boyd KL; Brindle PK
PLoS One; 2013; 8(12):e82684. PubMed ID: 24340053
[TBL] [Abstract][Full Text] [Related]
19. Two distinct motifs within the p53 transactivation domain bind to the Taz2 domain of p300 and are differentially affected by phosphorylation.
Jenkins LM; Yamaguchi H; Hayashi R; Cherry S; Tropea JE; Miller M; Wlodawer A; Appella E; Mazur SJ
Biochemistry; 2009 Feb; 48(6):1244-55. PubMed ID: 19166313
[TBL] [Abstract][Full Text] [Related]
20. The human T-cell leukemia virus type 1 tax protein confers CBP/p300 recruitment and transcriptional activation properties to phosphorylated CREB.
Geiger TR; Sharma N; Kim YM; Nyborg JK
Mol Cell Biol; 2008 Feb; 28(4):1383-92. PubMed ID: 18070920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
